VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 112 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17 | +21.4% | 133,868 | 0.0% | 0.00% | – |
| Q4 2022 | $14 | -99.9% | 133,868 | 0.0% | 0.00% | – |
| Q3 2022 | $20,000 | -93.4% | 133,868 | -61.4% | 0.00% | – |
| Q2 2022 | $305,000 | -33.0% | 346,662 | -5.6% | 0.00% | – |
| Q1 2022 | $455,000 | -36.5% | 367,044 | -0.0% | 0.00% | -100.0% |
| Q4 2021 | $716,000 | +94.6% | 367,052 | +173.6% | 0.00% | – |
| Q3 2021 | $368,000 | -28.7% | 134,173 | -18.1% | 0.00% | -100.0% |
| Q2 2021 | $516,000 | – | 163,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Performa Ltd (US), LLC | 4,900 | $9,163 | 0.01% |